 Home > Medical News > Latest Medical News > FDA today accelerates approval of GlaxoSmithKline PD-1 antibody to treat specific solid tumors

FDA today accelerates approval of GlaxoSmithKline PD-1 antibody to treat specific solid tumors

 Last Update: 2021-08-27
 Source: Internet
 Author: User

Tags

advanced biotech

hiv 1 antibody

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, GlaxoSmithKline (GSK) announced that the US FDA has accelerated the approval of the company’s PD-1 antibody Jemperli (dostarlimab-gxly) for extended indications for the treatment of relapsed or advanced stages with mismatch repair defects (dMMR) Patients with solid tumors

Mismatch repair defective tumor cells affect the normal repair of DNA damage during DNA replication

This approval is based on the results of a clinical trial called GARNET

Reference materials:

[1] FDA Grants Accelerated Approval of JEMPERLI (dostarlimab-gxly) for dMMR Recurrent or Advanced Solid Tumors.

[2] GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.